SEC Drops Probe Of Bankrupt Pharma Co. Dendreon
The U.S. Securities and Exchange Commission has closed a formal investigation of Dendreon Corp., the bankrupt maker of prostate cancer drug Provenge, and will not recommend bringing an enforcement action, the...To view the full article, register now.
Already a subscriber? Click here to view full article